| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 9.224 | 8.907 | 0 | 0 | 0 | 0 | 14.975 | 0 | 0 | 0 |
| Total Expenses - EUR | 8.290 | 8.207 | 6.605 | 4.274 | 5.719 | 9.298 | 58.933 | 548 | 910 | 543 |
| Gross Profit/Loss - EUR | 934 | 700 | -6.605 | -4.274 | -5.719 | -9.298 | -43.959 | -548 | -910 | -543 |
| Net Profit/Loss - EUR | 6 | 522 | -6.605 | -4.274 | -5.719 | -9.298 | -44.408 | -548 | -910 | -543 |
| Employees | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - R & D Irist Labmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 60.335 | 59.720 | 58.710 | 57.632 | 56.516 | 55.445 | 0 | 0 | 0 | 0 |
| Current Assets | 664 | 980 | 428 | 1.207 | 1.412 | 1.872 | 1.287 | 1.413 | 4.259 | 3.511 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 548 | 895 | 1.046 | 1.189 | 1.306 | 1.350 | 1.226 | 1.230 | 1.227 | 1.220 |
| Cash | 116 | 85 | -618 | 18 | 107 | 522 | 61 | 183 | 3.032 | 2.292 |
| Shareholders Funds | 944 | 1.456 | -5.174 | -9.353 | -14.891 | -23.907 | -67.784 | -68.542 | -69.244 | -69.400 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 60.056 | 59.244 | 64.312 | 68.192 | 72.819 | 81.223 | 69.072 | 69.955 | 73.503 | 72.911 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - R & D Irist Labmed Srl